PATENT CLAIM ANALYSIS

Application Number: 16000108
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "412000"]

Abstract:
The present invention provides compounds that modulate protein function, specifically phosphodiesterase 4 (PDE4). The invention provides methods of treating, ameliorating, and/or preventing diseases, disorders, and conditions associated with PDE4. Compositions, including in combination with other inflammatory mediators, are also provided.

Claim (Index 28):
The method of  claim 27 , wherein the disease, disorder, or condition is selected from the group consisting of arthritis, ankylosing spondylitis, osteoarthritis, rheumatoid arthritis, Behcet's disease, an inflammatory bowel disease, psoriasis, psoriatic arthritis, atopic dermatitis, contact dermatitis, and combinations thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12657801', '13830486', '14574007', '14552226', '13830712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8256612863507472
- 35 USC 102 Novelty (BERT): 0.5184996706567119
- Combined Prediction Score: 0.7949451247813437
- Mean Citation Score: 306.77598
- Max Citation Score: 310.447
- Similarity Product: 202.6914693990946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test